top of page

Thanks to ROS1ders’ Partner Turning Point Therapeutics

Updated: Feb 15, 2022

Jean Cui (right) and Miriam Cruz (left) of Turning Point Therapeutics with Janet Freeman-Daily of The ROS1ders

Thank you so much for inviting me to speak to your employees about my personal ROS1 lung cancer story and the work of The ROS1ders. I truly appreciate your willingness to consider a patient perspective on ways to improve awareness of and access to biomarker testing and clinical trials for cancer patients. A HUGE thank you for your generous gift to our ROS1ders fundraiser at the nonprofit GO2 Foundation for Lung Cancer! Your gift will help fund patient-driven research projects like our ROS1 Cancer Model Project, which has already generated four new ROS1 cell lines and three publications for our rare disease.

I look forward to a long and productive partnership as we work together to improve outcomes for all ROS1+ cancers.


Janet Freeman-Daily Cofounder, The ROS1ders

24 views0 comments


bottom of page